Paul Bebbington and Elizabeth Kuipers, two academics whose lives are now impacted by Paul’s diagnosis of Alzheimer’s, offer brave accounts of the day-to-day experiences of living with dementia and being a care provider in an initiative to reduce stigma.
The annual event brings together basic scientists, clinical researchers, early career investigators, clinicians and the care research community to discuss the latest developments and innovation in Alzheimer’s and dementia research.
ADI is pleased to welcome 6 new member associations, as well as new members to the ADI board.
During the 60-minute meeting, the advisory panel discussed ADI's activities over the last year, as well as proposals for future avenues of research, including a working group to explore the impact of COVID-19 as a potential risk factor for accelerating dementia.
The ADI Council met on 30 March 2021 to discuss ADI's activities over 2020, new membership applications and more.
The discussions focused on developing a regional policy brief for the promotion, protection and restoration of mental health in older adults, with the inclusion of a focus on dementia awareness and risk reduction.
Cohort Studies of Memory in an International Consortium
Phase II trial results found that donanemab slowed cognitive and functional decline in patients with early symptomatic Alzheimer's disease.
Lily Liu, a former communications professional in the non-profit sector, writes about her unique journey as an immigrant family caregiver in the United States and why she is a 'Dragon Daughter', even during the Year of the Ox.
Though Italy's National Dementia Plan was first approved in 2014, this is the first time that the plan will receive funding by the Italian government.